| Literature DB >> 34192206 |
Jessica Stander1, Jennifer C du Preez1, Chantel Kritzinger1, Natasha M Obermeyer1, Silke Struwig1, Nikki van Wyk1, Jessica Zaayman1, Marlette Burger1.
Abstract
BACKGROUND: Individuals with Down syndrome may struggle with anticipatory postural adjustments, and adapt slower to motor tasks and environmental changes, due to decreased motor proficiency.Entities:
Keywords: Down syndrome; motor proficiency; occupational therapy; physiotherapy; rehabilitation; virtual reality
Year: 2021 PMID: 34192206 PMCID: PMC8182459 DOI: 10.4102/sajp.v77i1.1516
Source DB: PubMed Journal: S Afr J Physiother ISSN: 0379-6175
FIGURE 1Preferred Reporting Items for Systematic Reviews and Meta-Analyses flow diagram.
Methodological quality of included studies.
| S. no. | PEDro criteria | Álvareza et al. ( | Ghafar and Raouf ( | Lin and Wuang ( | Rahman ( | Silva et al. ( | Wuang et al. ( |
|---|---|---|---|---|---|---|---|
| 1 | Eligibility criteria were specified. | Yes | Yes | Yes | Yes | Yes | Yes |
| 2 | Subjects were randomly allocated to groups (in a crossover study, subjects were randomly allocated an order in which treatments were received). | Yes | Yes | Yes | No | Yes | Yes |
| 3 | Allocation was concealed. | No | No | No | No | No | No |
| 4 | The groups were similar at baseline regarding the most important prognostic indicators. | Yes | Yes | Yes | Yes | Yes | Yes |
| 5 | There was blinding of all subjects. | No | No | No | No | No | No |
| 6 | There was blinding of all therapists who administered the therapy. | No | No | No | No | No | Yes |
| 7 | There was blinding of all the assessors who measured at least one key outcome. | No | Yes | Yes | No | Yes | Yes |
| 8 | Measures of at least one key outcome were obtained for more than 85% of the subjects initially added to the groups. | Yes | Yes | Yes | Yes | Yes | No |
| 9 | All subjects for whom outcome measures were available received the treatment or control condition as allocated or, where this was not the case, data for at least one key outcome was analysed by ‘intention to treat’. | Yes | Yes | Yes | Yes | Yes | No |
| 10 | The results of between-groups statistical comparisons are reported for at least one key outcome. | Yes | Yes | Yes | Yes | Yes | Yes |
| 11 | The study provides both point measures and measures of variability for at least one key outcome. | Yes | Yes | Yes | Yes | Yes | Yes |
Source: Maher, C.G., Sherrington, C., Herbert, R.D., Moseley, A.M. & Elkins, M., 2003, ‘Reliability of the PEDro Scale for rating quality of randomized controlled trials’, Physical Therapy 83(8), 713–721
Study sample description.
| Criteria | Groups | Álvareza et al. ( | Ghafar and Abdelraouf ( | Lin and Wuang ( | Rahman ( | Silva et al. ( | Wuang et al. ( | Berg et al. ( |
|---|---|---|---|---|---|---|---|---|
| Sample size ( | Experimental | |||||||
| Control | - | |||||||
| Gender ( | Experimental | Female = 3 | Not specified | Female = 25 | Female = 9 | Not specified | Not specified | Male |
| Control | - | Not specified | Female = 24 | Female = 8 | Not specified | Not specified | - | |
| Age mean (SD) (years) | Experimental | 8.30 ± 2.06 | 7.18 ± 1.85 | 15.6 ± 3.6 | 10.92 ± 1.16 | 18–60 years | 7–12 years | 12-year-old |
| Control | 8.43 ± 1.62 | 7.40 ± 1.27 | 14.9 ± 3.9 | 11.56 ± 0.44 | 18–60 years | 7–12 years | - | |
| Baseline difference reported | Experimental | No baseline differences reported | No baseline differences reported | No baseline differences reported | No baseline differences reported | No baseline differences reported | No baseline differences reported | Not applicable |
| Control | No baseline differences reported | No baseline differences reported | No baseline differences reported | No baseline differences reported | No baseline differences reported | No baseline differences reported | Not applicable | |
| Country of study | - | Chile | Saudi Arabia | Taiwan | Saudi Arabia | Portugal | Taiwan | USA |
| Type of study | - | Quasi-experimental | Randomised controlled trial | Randomised controlled trial | Quasi-experimental | - | Quasi-experimental | Case study |
SD, standard deviation; SOT, standard occupational therapy; USA, United States of America.
Description of intervention and control procedures.
| Groups | Variables | Álvareza et al. ( | Ghafar and Abdelraouf ( | Lin and Wuang ( | Rahman ( | Silva et al. ( | Wuang et al. ( | Berg et al. ( |
|---|---|---|---|---|---|---|---|---|
| Experimental group: Nintendo Wii Games | Type of Nintendo Wii Games | Wii fit software, along with the Wii balance board. The following games were practised: Snowboarding, the Penguin Slide, Super Hoola Hoop, heading Soccer and Skii Jumping. | Wii Sports, Wii Fit, Wii balance board. The following three Wii games were practised: Football heading game, Ski Slalom game and, finally, the Table Tilt game. | Wii Sports games. The five most popular games being Boxing, bowling, table tennis, Frisbee and golfing. | Wii Fit with Wii balance board, Wii console, Wii remote and Wii nun chuck. Balance games: Soccer heading game, Tightrope walk game, Penguin slide game As well as the following: Approximation and strengthening exercises, walking on an even surface in the treatment room and climbing stairs. | Wii fit balance board. Games targeting balance or isometric strength: Freerun, Heading, Snowboard Slalom, Table tilt, Tight rope tension, Hoolahoop, Balance bubble, Penguin slide Wii Sports, Wii Sports Resort, Wii Fit and Just Dance 2 targeted aerobic endurance. Games performed: Sword play, Boxing, Cycling, Table tennis, Just Dance 2. | A Nintendo Wii gaming console, that is, Wii Sports. | Wii Sports bowling, baseball, rhythm boxing and snowboarding game. |
| Frequency and dosage of intervention | The intervention was 5 weeks with two weekly sessions of 20-min duration. | Treatment sessions consisted of 30 min, three times per week for 8 weeks. Each game was played for 10 min. | Treatment sessions consisted of three 35-min sessions per week for 6 weeks. | Approximation and strengthening exercises (15 min, 5-min rest) | Participants completed 1 h session, three times per week, to 22 sessions over a period of 2 months. | Treatment sessions consisted of 1 h, 2 days per week for 24 weeks. | Participant asked to use Wii 20 min, four times per week for 8 weeks. | |
| Control group: SPT; SOT; No intervention | Method of SPT or SOT | Continued normal daily activities along with psycho-educational therapies included in school. | Throwing or catching balls or beanbags outside of their base of support, reaching for objects whilst standing or sitting on stable or unstable surfaces, walking up and down stairs, balance beam walk, single-leg stance and kicking activities. Individualised treatments based on functional limitations and abilities of child. | No intervention. | Approximation or strengthening exercises. Walking on an even surface in the treatment room and climbing stairs. | The control group completed their usual daily activities, such as vocational rehabilitation, life-skill training and art-related activities. | Various activity combinations incorporating the principle of sensory integrative therapy, neuro developmental treatment, and perceptual motor approaches. | Not applicable. |
| Frequency and dosage of intervention | None reported. | Treatment sessions consisted of 30 min, three times per week for 8 weeks. | None reported. | Approximation or strengthening exercises (15 min, 5 min rest). Walking on even surfaces and climbing stairs for 35 min (15 min each and 5 min rest in between). Programme performed twice a week for 6/52. | None was mentioned or specified. | Treatment sessions consisted of 30 min, three times per week for 8 weeks. | Not applicable. |
SPT, standard physiotherapy; SOT, standard occupational therapy.
Results reported for balance measures of included studies.
| Study | Assessment interval | Test description | Control | Experimental group | Mean difference between groups (95% CI) | |||
|---|---|---|---|---|---|---|---|---|
| mean | (SD) | mean | (SD) | |||||
| Álvareza et al. ( | Baseline | Pressure centre eyes open (m2) | 0.06 | 0.05 | 0.06 | 0.04 | 0.00 (−0.05 to 0.05) | 0.83 |
| 5 weeks | 0.04 | 0.03 | 0.07 | 0.005 | 0.03 (0.01 to 0.05) | 0.31 | ||
| 0.36 | - | 0.52 | - | - | - | |||
| Sample size ( | 7 | - | 9 | - | - | - | ||
| Baseline | Pressure centre eyes closed (m2) | 0.05 | 0.02 | 0.05 | 0.03 | 0.00 (−0.03 to 0.03) | 0.86 | |
| 5 weeks | 0.04 | 0.02 | 0.02 | 0.019 | −0.02 (−0.04 to 0.00) | 0.13 | ||
| 0.31 | - | 0.039* | - | - | - | |||
| Sample size ( | 7 | - | 9 | - | - | - | ||
| Ghafar and Abdelraouf ( | Baseline | Pediatric balance test | 47.35 | 3.8 | 48.2 | 4.6 | 0.85 (−2.57 to 4.27) | 0.046 |
| 8 weeks | 52.15 | 4.7 | 57.75 | 2.6 | 5.60 (2.53 to 8.67) | - | ||
| Not reported | - | Not reported | - | - | - | |||
| Sample size ( | 13 | - | 13 | - | - | - | ||
| Baseline | Timed up and go test | 10.65 | 1.7 | 10.21 | 2.0 | −0.44 (−1.94 to 1.06) | 0.043 | |
| 8 weeks | 8.95 | 1.4 | 7.01 | 1.8 | 1.94 (0.63 to 3.25) | - | ||
| Not reported | - | Not reported | - | - | - | |||
| Sample size ( | 13 | - | 13 | - | - | - | ||
| Baseline | Five times sit to stand test | 16.56 | 2.3 | 15.6 | 2.6 | −0.96 (−2.95 to 1.03) | 0.027 | |
| 8 weeks | 14.62 | 3.2 | 11.2 | 2.9 | −3.42 (−5.89 to −0.95) | - | ||
| Not reported | - | Not reported | - | - | - | |||
| Sample size ( | 13 | - | 13 | - | - | - | ||
| Rahman ( | Baseline | BOT-2 balance subsection | 8.87 | 5.53 | 10.27 | 4.83 | 1.4 (−2.48 to 5.28) | 0.466 |
| 6 weeks | 10.40 | 4.93 | 17.47 | 3.50 | 7.01 (3.87 to 10.27) | 0.000 | ||
| 0.017 | - | 0.000 | - | - | - | |||
| Sample size ( | 15 | - | 15 | - | - | - | ||
| Silva et al. ( | Baseline | Flamingo balance test | 3.31 | 8.20 | 6.08 | 11.09 | 2.77 (−5.25 to 10.79) | 0.477 |
| 24 weeks | 1.69 | 6.10 | 9.92 | 12.53 | 8.23 (0.18 to 16.28) | - | ||
| Effect size – within group ( | 0.228 | - | 0.372 | - | - | - | ||
| Sample size ( | 13 | - | 12 | - | - | - | ||
| Wuang et al. ( | Baseline | BOT-2 balance subsection | 11.40 | 8.91 | 11.08 | 7.02 | −0.32 (−3.43 to 2.79) | < 0.003 |
| 24 weeks | 12.66 | 7.99 | 13.27 | 8.91 | 0.61 (−2.66 to 3.88) | - | ||
| Effect size – within group ( | 0.72 | - | 1.60 | - | - | - | ||
| Sample size ( | 53 | - | 52 | - | - | - | ||
SD, standard deviation; CI, confidence interval; BOT-2, Bruininks–Oseretsky Test of Motor Proficiency, Second edition.
Results reported for agility measures of included studies.
| Study | Assessment interval | Test description | Control | Experimental group | Mean difference between groups (95% CI) | |||
|---|---|---|---|---|---|---|---|---|
| mean | (SD) | Mean | (SD) | |||||
| Álvareza et al. ( | Baseline | TGMD-2 locomotion subsection | 33.71 | 3.69 | 34.56 | 5.94 | 0.85 (−5.85 to 7.55) | 0.75 |
| 5 weeks | 33.71 | 4.82 | 36.67 | 3.39 | 2.96 (−1.43 to 7.35) | 0.17 | ||
| 1.00 | - | 0.3 | - | - | - | |||
| Sample size ( | 7 | - | 9 | - | - | - | ||
| Lin and Wuang ( | Baseline | BOT-2 agility subsection | 11.0 | 5.9 | 11.0 | 6.3 | 0.00 (−2.53 to 2.53) | 0.466 |
| 6 weeks | 10.0 | 6.8 | 16.0 | 6.6 | 6.0 (3.22 to 8.78) | 0.01 | ||
| Not reported | - | Not reported | - | - | - | |||
| Sample size ( | 46 | - | 46 | - | - | - | ||
| Silva et al. ( | Baseline | Shuttle run test | 33.01 | 5.69 | 35.42 | 12.55 | 2.41 (−5.54 to 10.36) | 0.014 |
| 24 weeks | 35.31 | 9.06 | 31.62 | 6.32 | −3.69 (−10.21 to 2.83) | - | ||
| Effect size – within group ( | 0.508 | - | 0.478 | - | - | - | ||
| Sample size ( | 13 | - | 12 | - | - | - | ||
| Wuang et al. ( | Baseline | BOT-2 agility subsection | 7.47 | 5.58 | 7.38 | 5.48 | −0.09 (−2.23 to 2.05) | < 0.003 |
| 24 weeks | 9.36 | 6.81 | 10.12 | 5.64 | 0.76 (−1.66 to 3.18) | - | ||
| Effect size – within group ( | 1.89 | - | 2.56 | - | - | - | ||
| Sample size ( | 53 | - | 52 | - | - | - | ||
SD, standard deviation; CI, confidence interval; BOT–2, Bruininks–Oseretsky Test of Motor Proficiency, Second edition; Test of Gross Motor Development, Second Edition.
Results reported for strength measures of included studies.
| Study | Assessment interval | Test description | Control | Experimental group | Mean difference between groups (95% CI) | |||
|---|---|---|---|---|---|---|---|---|
| mean | (SD) | mean | (SD) | |||||
| Lin and Wuang ( | Baseline | BOT-2 strength subsection | 10.94 | 1.59 | 10.69 | 1.25 | −0.25 (−0.84 to 0.34) | 0.466 |
| 6 weeks | 14.36 | 1.87 | 15.37 | 1.80 | 1.01 (0.25 to 1.77) | 0.000 | ||
| Not reported | - | Not reported | - | - | - | |||
| Sample size ( | 46 | - | 46 | - | - | - | ||
| Silva et al. ( | Baseline | Handgrip test | 22.38 | 5.91 | 23.67 | 6.89 | 1.29 (−4.01 to 6.59) | 0.837 |
| 24 weeks | 23.92 | 6.45 | 25.42 | 5.53 | 1.5 (−3.49 to 6.49) | - | ||
| Effect size – within group ( | 0.693 | - | 0.618 | - | - | - | ||
| Sample size ( | 13 | - | 12 | - | - | - | ||
| Baseline | 30-s sit-up | 9.96 | 5.44 | 7.17 | 5.51 | −2.79 (−7.32 to 1.74) | 0.040 | |
| 24 weeks | 7.69 | 5.22 | 8.00 | 5.36 | 0.21 (−4.17 to 4.59) | - | ||
| Effect size – within group ( | 0.585 | - | 0.271 | - | - | - | ||
| Sample size ( | 13 | 12 | - | - | - | |||
| Baseline | Standing broad jump | 88.04 | 44.02 | 82.67 | 31.52 | −5.37 (−37.29 to 26.55) | 0.003 | |
| 24 weeks | 90.69 | 35.20 | 99.33 | 29.49 | 8.64 (−18.35 to 35.63) | - | ||
| Effect size – within group ( | 0.235 | - | 1.691 | - | - | - | ||
| Sample size ( | 13 | - | 12 | - | - | - | ||
| Wuang et al. ( | Baseline | BOT-2 strength subsection | 10.94 | 8.14 | 10.69 | 6.40 | −0.25 (3.09 to 2.59) | < 0.003 |
| 24 weeks | 14.36 | 9.58 | 15.37 | 9.22 | 1.01 (−2.63 to 4.65) | - | ||
| Effect size – within group ( | 2.15 | - | 3.74 | - | - | - | ||
| Sample size ( | 53 | - | 52 | - | - | - | ||
SD, standard deviation; CI, confidence interval; BOT-2, Bruininks–Oseretsky Test of Motor Proficiency, Second edition.
Results reported for coordination measures of included studies.
| Study | Assessment interval | Test description | Control | Experimental group | Mean difference between groups (95% CI) | |||
|---|---|---|---|---|---|---|---|---|
| mean | (SD) | mean | (SD) | |||||
| Álvareza et al. ( | Baseline | TGMD-2 manipulation subsection | 30.14 | 6.67 | 28.44 | 5.46 | −1.7 (−8.19 to 4.79) | 0.58 |
| 5 weeks | 29.43 | 5.86 | 35.00 | 5.50 | 5.57 (−0.54 to 11.68) | 0.07 | ||
| 0.09 | - | 0.01* | - | - | - | |||
| Sample size ( | 7 | - | 9 | - | - | - | ||
| Silva et al. ( | Baseline | Bean bag overhead throw test: Right hand | 6.69 | 3.38 | 5.17 | 3.76 | −1.52 (−4.47 to 1.43) | 0.150 |
| 24 weeks | 5.23 | 2.89 | 6.67 | 3.11 | 1.44 (−1.042 to 3.92) | - | ||
| Effect size – within group ( | 0.478 | - | 0.591 | - | - | - | ||
| Sample size ( | 13 | - | 12 | - | - | - | ||
| Baseline | Beanbag overhead throw test: Left hand | 8.15 | 3.76 | 6.92 | 3.53 | −1.23 (−4.25 to 1.79) | 0.083 | |
| 24 weeks | 5.38 | 3.15 | 6.67 | 3.37 | 1.29 (−1.4 to 3.99) | - | ||
| Effect size – within group ( | 0.635 | - | 0.010 | - | - | - | ||
| Sample size ( | 13 | - | 12 | - | - | - | ||
| Wuang et al. ( | Baseline | Upper limb coordination | 8.11 | 1.12 | 7.96 | 1.14 | −0.15 (−0.59 to 0.29) | <0.003 |
| 24 weeks | 9.32 | 2.44 | 10.62 | 2.64 | 1.3 (0.32 to 2.28) | - | ||
| Effect size – within group ( | 1.08 | - | 2.33 | - | - | - | ||
| Sample size ( | 53 | - | 52 | - | - | - | ||
| Baseline | Bilateral coordination | 10.94 | 8.14 | 10.69 | 6.40 | −0.25 (−3.09 to 2.59) | < 0.003 | |
| 24 weeks | 14.36 | 9.58 | 15.37 | 9.22 | 1.01 (−2.63 to 4.65) | - | ||
| Effect size – within group ( | 0.96 | - | 1.90 | - | - | - | ||
| Sample size ( | 53 | - | 52 | - | - | - | ||
SD, standard deviation; CI, confidence interval; BOT-2, Bruininks–Oseretsky test of Motor Proficiency, Second edition.
Preferred Reporting Items for Systematic Reviews and Meta-Analyses checklist for systematic reviews and meta-analyses.
| Section or topic | # | Checklist item | Page # |
|---|---|---|---|
| Title | 1 | Identify the report as a systematic review, meta-analysis, or both. | 1 |
| Structured summary | 2 | Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and implications of key findings; systematic review registration number. | 2–3 |
| Rationale | 3 | Describe the rationale for the review in the context of what is already known. | 6 |
| Objectives | 4 | Provide an explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design (PICOS). | 7 |
| Protocol and registration | 5 | Indicate if a review protocol exists, if and where it can be accessed (e.g. Web address), and, if available, provide registration information, including registration number. | 6 |
| Eligibility criteria | 6 | Specify study characteristics (e.g. PICOS, length of follow-up) and report characteristics (e.g. years considered, language, publication status) used as criteria for eligibility, giving rationale. | 8–9 |
| Information sources | 7 | Describe all information sources (e.g. databases with dates of coverage, contact with study authors to identify additional studies) in the search and date last searched. | 7–8 |
| Search | 8 | Present full electronic search strategy for at least one database, including any limits used, such that it could be repeated. | App. B |
| Study selection | 9 | State the process for selecting studies (i.e. screening, eligibility, included in systematic review, and, if applicable, included in the meta-analysis). | 9–10 |
| Data collection process | 10 | Describe method of data extraction from reports (e.g. piloted forms, independently, in duplicate) and any processes for obtaining and confirming data from investigators. | 10 |
| Data items | 11 | List and define all variables for which data were sought (e.g. PICOS, funding sources) and any assumptions and simplifications made. | 9 |
| Risk of bias in individual studies | 12 | Describe methods used for assessing risk of bias of individual studies (including specification of whether this was done at the study or outcome level), and how this information is to be used in any data synthesis. | 10 |
| Summary measures | 13 | State the principal summary measures (e.g. risk ratio, difference in means). | 12 |
| Synthesis of results | 14 | Describe the methods of handling data and combining results of studies, if done, including measures of consistency (e.g. I2) for each meta-analysis. | N/A |
| Risk of bias across studies | 15 | Specify any assessment of risk of bias that may affect the cumulative evidence (e.g. publication bias, selective reporting within studies). | N/A |
| Additional analyses | 16 | Describe methods of additional analyses (e.g. sensitivity or subgroup analyses, meta-regression), if done, indicating which were pre-specified. | N/A |
| Study selection | 17 | Give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage, ideally with a flow diagram. | 10–11 |
| Study characteristics | 18 | For each study, present characteristics for which data were extracted (e.g. study size, PICOS, follow-up period) and provide the citations. | 14 |
| Risk of bias within studies | 19 | Present data on risk of bias of each study and, if available, any outcome level assessment (see item 12). | N/A |
| Results of individual studies | 20 | For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for each intervention group (b) effect estimates and confidence intervals, ideally with a forest plot. | 14–17 |
| Synthesis of results | 21 | Present results of each meta-analysis done, including confidence intervals and measures of consistency. | N/A |
| Risk of bias across studies | 22 | Present results of any assessment of risk of bias across studies (see Item 15). | N/A |
| Additional analysis | 23 | Give results of additional analyses, if done (e.g. sensitivity or subgroup analyses, meta-regression [see Item 16]). | N/A |
| Summary of evidence | 24 | Summarise the main findings including the strength of evidence for each main outcome; consider their relevance to key groups (e.g. healthcare providers, users, and policymakers). | 18–19 |
| Limitations | 25 | Discuss limitations at study and outcome level (e.g. risk of bias), and at review-level (e.g. incomplete retrieval of identified research, reporting bias). | 20–21 |
| Conclusions | 26 | Provide a general interpretation of the results in the context of other evidence, and implications for future research. | 18–19 |
| Funding | 27 | Describe sources of funding for the systematic review and other support (e.g. supply of data); role of funders for systematic review. | 24 |
Source: Moher, D., Liberati, A., Tetzlaff, J. & Altman, D.G., 2009, ‘Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement’, Annals of Internal Medicine 151(4), 264–269
| Yes | No | Unclear | Not applicable | |
|---|---|---|---|---|
| Were patient’s demographic characteristics clearly described? | - | □ | X | □ |
| Was the patient’s history clearly described and presented as a timeline? | □ | X | □ | □ |
| Was the current clinical condition of the patient on presentation clearly described? | X | □ | □ | □ |
| Were diagnostic tests or assessment methods and the results clearly described? | X | □ | □ | - |
| Was the intervention(s) or treatment procedure(s) clearly described? | X | □ | □ | □ |
| Was the post-intervention clinical condition clearly described? | X | □ | □ | □ |
| Were adverse events (harms) or unanticipated events identified and described? | X | □ | □ | □ |
| Does the case report provide takeaway lessons? | X | □ | □ | □ |
Overall appraisal: Include: YES; Exclude □ Seek further info □
Comments (Including reason for exclusion)
Good takeaway lesson and reinforces the overall message of our systematic review
Description of outcome measures.
| Variable | Description |
|---|---|
| BOT-2 | Bruininks-Oseretsky Test of Motor Proficiency (BOTMP) is similar to the Bruininks–Oseretsky Test of Motor Proficiency-Second Edition (BOT-2). The BOT-2 is a shorter version but still measures the same components as the BOTMP with the same activities. Rahman ( |
| Eurofit Test Battery | This is a physical fitness test consisting of numerous domains (Oja & Tuxworth |
| Handgrip test | The handgrip strength test is designed to replicate the grip strength required to hold objects such as the wii-remote. The test is completed using a dynamometer that measures grip strength in kilograms (Bechtol |
| Standing Broad Jump | Standing broad jump is used to measure explosive leg power. The test is executed with the participant standing behind a line drawn on the floor. The participant then jumps forward from a still standing position and the distance jumped is measured from the starting line to the back of the heels (Glencross |
| Beanbag Overhead Throw | The beanbag overhead throw involves throwing a beanbag over the ipsi-lateral shoulder in the direction of a hoop located at the centre of a gymnastic mat. It is performed standing 2 m away from the mat facing away from the mat. This tests spatial orientation and mental rotation (Carmeli et al. 2008). |
| Pediatric Balance Scale (PBS) | The Berg Balance Scale has been modified to create the PBS. The PBS is specifically used to assess balance in young children that present with mild to moderate disabilities, and it has already been established that the PBS is a reliable and valid tool for the measurement of balance (Franjoine et al. |
| Timed-up-and-go test | This test measures the time it takes for an individual to stand up from an armchair, walk 3 m, turn around, and sit back in the chair again. It was originally developed to measure the functional ability of elderly people who were at risk of falling. The timed-up-and-go test has been proven to be a reliable test when assessing the functional mobility of individuals with Down syndrome. This is a good test to use as it is easily re-producible (Nicolini-Panisson & Donadio |
| Five-times-sit-to-stand test | The Five-times-sit-to-stand-test can be used to assess the ability to perform transitional movements and it is a reliable test to use for the measurement of balance (Posiadlo & Richardson |
| TGMD-2 | The TGMD-2 is a tool used to identify deficits in gross motor development in children between the age of 3 and 10 years, evaluating 12 skills, grouped into two categories, namely locomotor skills and object control skills (Álvareza et al. |
| Pressure Centre | Berg ( |
TGMD-2, Test of Gross Motor Development, Second Edition.